Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Neuromod, an Ireland-based neuromodulation technology developer spun out from Maynooth University, has closed an €8m ($8.7m) equity and debt round led by Fountain Healthcare Partners with participation from Moffett Investment Holdings, Kreos Capital and Silicon Valley Bank. Proceeds from the round will help scale up the European manufacturing capacity to support the commercialisation of its Lenire tinnitus treatment, while also preparing the ground for regulatory submissions in the US. Neuromod received $6.2m of series A capital from Fountain Healthcare Partners…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?